No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs191500359 |
chr3:69374738-69374739 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs564101024 |
chr3:69374787-69374788 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs34428822 |
chr3:69374793-69374794 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs536916176 |
chr3:69374912-69374913 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs553715656 |
chr3:69374916-69374917 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs566828253 |
chr3:69374920-69374921 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs539085130 |
chr3:69374949-69374950 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs78728909 |
chr3:69374993-69374994 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs187849907 |
chr3:69374994-69374995 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs544374403 |
chr3:69375037-69375038 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs554441034 |
chr3:69375038-69375039 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs9876410 |
chr3:69375057-69375058 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs191471149 |
chr3:69375079-69375080 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs560017878 |
chr3:69375092-69375093 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs531977559 |
chr3:69375094-69375095 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs146083122 |
chr3:69375124-69375125 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs144852048 |
chr3:69375133-69375134 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs72335731 |
chr3:69375134-69375135 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs397758184 |
chr3:69375144-69375145 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs562586602 |
chr3:69375158-69375159 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs531331812 |
chr3:69375200-69375201 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs548286477 |
chr3:69375233-69375234 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs371350022 |
chr3:69375270-69375271 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs567720693 |
chr3:69375333-69375334 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs183612461 |
chr3:69375354-69375355 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs559818210 |
chr3:69375373-69375374 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs547313080 |
chr3:69375433-69375434 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs567214674 |
chr3:69375439-69375440 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs539021168 |
chr3:69375460-69375461 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs552320195 |
chr3:69375472-69375473 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs569257524 |
chr3:69375486-69375487 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs186787290 |
chr3:69375503-69375504 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs140084738 |
chr3:69375531-69375532 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs555056176 |
chr3:69375560-69375561 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs574245112 |
chr3:69375575-69375576 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs529645412 |
chr3:69375647-69375648 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs4855388 |
chr3:69375655-69375656 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
38 |
rs559404370 |
chr3:69375672-69375673 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs553639066 |
chr3:69375677-69375678 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs192654935 |
chr3:69375716-69375717 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs144075613 |
chr3:69375724-69375725 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs562314734 |
chr3:69375736-69375737 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs576000724 |
chr3:69375740-69375741 |
Weak transcription Enhancers Flanking Active TSS Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs528504094 |
chr3:69375817-69375818 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs116641380 |
chr3:69375822-69375823 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs545380865 |
chr3:69375836-69375837 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs185494702 |
chr3:69375877-69375878 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs547250928 |
chr3:69375981-69375982 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs560747801 |
chr3:69376012-69376013 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs532667032 |
chr3:69376031-69376032 |
Weak transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|